|
MIF expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.86619999999316E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.202860E-03 |
| Normal-vs-Stage2 |
1.664030E-01 |
| Normal-vs-Stage3 |
4.361600E-04 |
| Normal-vs-Stage4 |
3.544200E-02 |
| Stage1-vs-Stage2 |
8.414600E-01 |
| Stage1-vs-Stage3 |
2.798200E-02 |
| Stage1-vs-Stage4 |
2.725800E-01 |
| Stage2-vs-Stage3 |
1.165970E-01 |
| Stage2-vs-Stage4 |
3.319800E-01 |
| Stage3-vs-Stage4 |
7.638800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.78154000000097E-05 |
| Normal-vs-AfricanAmerican |
4.894000E-02 |
| Normal-vs-Asian |
3.671000E-01 |
| Caucasian-vs-AfricanAmerican |
9.482300E-02 |
| Caucasian-vs-Asian |
8.290200E-01 |
| AfricanAmerican-vs-Asian |
6.892000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.29439999999137E-05 |
| Normal-vs-Female |
2.192200E-02 |
| Male-vs-Female |
2.535200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.648700E-04 |
| Normal-vs-Extreme_Weight |
4.36719999999946E-05 |
| Normal-vs-Obese |
5.520600E-03 |
| Normal-vs-Extreme_Obese |
4.254000E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.179600E-01 |
| Normal_Weight-vs-Obese |
4.848200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.399400E-01 |
| Extreme_Weight-vs-Obese |
5.324000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.102000E-01 |
| Obese-vs-Extreme_Obese |
3.322600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.131600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.339700E-03 |
| Normal-vs-Age(61-80Yrs) |
2.00719999999821E-05 |
| Normal-vs-Age(81-100Yrs) |
5.491200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.172600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.118000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.536400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.007200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.437000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.977780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.605700E-04 |
| Normal-VS-Type2 PRCC |
7.279900E-03 |
| Normal-VS-KIRP CIMP |
7.155800E-02 |
| Normal-VS-Unclassified PRCC |
7.389600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.502800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.748200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.645400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.752000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.078800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.221400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.045000E-04 |
| Normal-vs-N1 |
7.579900E-03 |
| Normal-vs-N2 |
1.997760E-01 |
| N0-vs-N1 |
8.187000E-01 |
| N0-vs-N2 |
4.807200E-01 |
| N1-vs-N2 |
5.938000E-01 |
|
|
